Real-World Evaluation of Calcimimetics for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease, in an Italian Clinical Setting

Real-World Evaluation of Calcimimetics for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease, in an Italian Clinical Setting

This Italian real-world data analysis evaluated the pharmaco-utilization of calcimimetics, cinacalcet or etelcalcetide, and the economic burden of secondary hyperparathyroidism (SHPT) in chronic kidney disease (CKD) patients. From 1 January 2010 to 30 June 2020, adult patients with: (i) ≥1 prescript...

Full description

Bibliographic Details
Main Authors: Valentina Perrone, Melania Dovizio, Chiara Veronesi, Margherita Andretta, Fausto Bartolini, Arturo Cavaliere, Fulvio Ferrante, Alessandro Lupi, Romina Pagliaro, Rita Pagnotta, Stefano Palcic, Davide Re, Loredana Ubertazzo, Adriano Vercellone, Luca Degli Esposti
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Healthcare
Subjects:
calcimimetics
real-world data
healthcare costs
Online Access:https://www.mdpi.com/2227-9032/10/4/709

Internet

https://www.mdpi.com/2227-9032/10/4/709

Similar Items